Additionally, it has been found that limiting neutrophils infiltration into the pancreatic tumor and lung cancer by CXCR2 inhibitor can promote tumor infiltration of CD8+ T cells and enhance their anti-tumor abilities 50, 51. The gene discussed is CD8A; the disease is lung cancer.